Ipek Yonal Hindilerden (İpek Yönal Hindilerden)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 2

Top Topics

Hodgkin Lymphoma

Diffuse Large B Cell Lymphoma

Monoclonal Antibody

Ejection Fraction

Top Venues

Turkish journal of haematology : official journal of Turkish Society of Haematology

Hematological oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Murat Özbalak, Metban Güzel Mastanzade, Özden Özlük, Tarık Onur Tiryaki, Sevgi Kalayoğlu-Beşışık, Ezgi Pınar Özbalak, Tuğrul Elverdi, Ipek Yonal Hindilerden, Ali Yılmaz Altay, Gulcin Yegen, Ahmet Emre Eskazan, Muhlis Cem Ar, Mustafa Nuri Yenerel, Teoman Soysal, Meliha Nalçacı, Burhan Ferhanoğlu, Sevgi Kalayoglu Besisik
Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience Turkish journal of haematology : official journal of Turkish Society of Haematology 39 (4) (2022)
Olga Meltem Akay Yanar, Murat Özbalak, Mustafa Pehlivan, Birol Yildiz, Ant Uzay, Tuğçe Nur Yiğenoğlu, Tuğrul Elverdi, Leylagul Kaynar, Orhan Ayyildiz, Ipek Yonal Hindilerden, Hasan Sami Goksoy, Sebnem Izmir Guner, Ahmet Kursad Gunes, Mehmet Sonmez, Meltem Kurt Yüksel, Sinem Civriz Bozdag, Zübeyde Nur Özkurt, Tayfur Toptas, Mehmet Hilmi Dogu, Ozan Salim, Guray Saydam, Irfan Yavasoglu, Meltem Ayli, Gulsum Ozet, Murat Albayrak, Elif Birtaş Ateşoğlu, Selami Kocak Toprak, Rahsan Yildirim, Özgür Mehta, Sevgi Kalayoglu Besisik, Meliha Nalçacı, Fevzi Altuntas, Burhan Ferhanoğlu
Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective study. Hematological oncology 39 (4) (2021)